These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 536284)

  • 1. Fibrinogenolysis and fibrinolysis with strenuous exercise.
    Ferguson EW; Barr CF; Bernier LL
    J Appl Physiol Respir Environ Exerc Physiol; 1979 Dec; 47(6):1157-61. PubMed ID: 536284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic activity without fibrinogenolysis during long-distance racing in horses.
    Ferguson EW; Bernier LL; Shaughness GP; Boucher JH
    J Appl Physiol Respir Environ Exerc Physiol; 1981 Feb; 50(2):245-9. PubMed ID: 7204198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinopeptide A after strenuous physical exercise at high altitude.
    Bärtsch P; Schmidt EK; Straub PW
    J Appl Physiol Respir Environ Exerc Physiol; 1982 Jul; 53(1):40-3. PubMed ID: 6811525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB; Bradford TR; Littman BH; Wintroub BU
    J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of fibrin formation in exercise-induced activation of coagulation.
    Vogt A; Hofmann V; Straub PW
    Am J Physiol; 1979 Apr; 236(4):H577-9. PubMed ID: 434223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolysis and fibrinogenolysis in disseminated intravascular coagulation.
    Takahashi H; Tatewaki W; Wada K; Niwano H; Shibata A
    Thromb Haemost; 1990 Jun; 63(3):340-4. PubMed ID: 2402738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of exercise and conditioning on clotting and fibrinolytic activity in men.
    Ferguson EW; Bernier LL; Banta GR; Yu-Yahiro J; Schoomaker EB
    J Appl Physiol (1985); 1987 Apr; 62(4):1416-21. PubMed ID: 3597218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turnover of fibrinogen, plasminogen, and prothrombin during exercise in man.
    Collen D; Semeraro N; Tricot JP; Vermylen J
    J Appl Physiol Respir Environ Exerc Physiol; 1977 Jun; 42(6):865-73. PubMed ID: 142076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of fibrinogenolysis in patients with closed head injury.
    Kushimoto S; Shibata Y; Yamamoto Y
    J Neurotrauma; 2003 Apr; 20(4):357-63. PubMed ID: 12866815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise-induced fibrinolysis--fact or fiction?
    Marsh NA; Gaffney PJ
    Thromb Haemost; 1982 Oct; 48(2):201-3. PubMed ID: 6217583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ; Marder VJ
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure of soluble fibrin complexes and fibrin degradation products after Echis carinatus bite.
    Edgar W; Warrell MJ; Warrell DA; Prentice CR
    Br J Haematol; 1980 Mar; 44(3):471-81. PubMed ID: 7378311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific identification of fibrin polymers, fibrinogen degradation products, and crosslinked fibrin degradation products in plasma and serum with a new sensitive technique.
    Connaghan DG; Francis CW; Lane DA; Marder VJ
    Blood; 1985 Mar; 65(3):589-97. PubMed ID: 3971042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the formation of fibrin clot in cirrhotic patients. An approach to study of acquired dysfibrinogenemia.
    Regañón E; Vila V; Aznar J; Garrido G; Estellés A; Berenguer J
    Thromb Res; 1987 Jun; 46(5):705-14. PubMed ID: 3629544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin degradation products. A review of structures found in vitro and in vivo.
    Gaffney PJ
    Ann N Y Acad Sci; 2001; 936():594-610. PubMed ID: 11460518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the fibrinolytic system during nonpregnant and pregnant oestrous cycles of bitches.
    Bunck CF; Mischke R; Günzel-Apel AR
    J Reprod Fertil Suppl; 2001; 57():207-14. PubMed ID: 11787151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.